Life Sciences Due Diligence Process Description

This document is a guide detailing the life sciences due diligence process, focusing on the legal risks involved in transactions within this sector. It outlines how Epstein Becker Green assists clients, particularly private equity firms and investors, in navigating regulatory landscapes and compliance matters prior to completing acquisitions. The importance of thorough due diligence is emphasized, as neglecting to evaluate a target's regulatory status can lead to significant financial repercussions. The guide explains the steps involved in creating a due diligence plan, which includes assembling teams of attorneys and advisors to identify potential risks associated with the target's products, services, and revenues. Furthermore, it documents the review of various compliance issues, marketing activities, and inspection histories to ensure clients are fully informed of any regulatory problems. The communication of findings throughout the process is also detailed, which aids clients in shaping their investment strategies and post-closing plans.